LNTH

Lantheus Holdings, Inc. NGM · LNTH

$103.85 -0.76 (-0.73%)

Neutral · -0.33σ Grade C

+ Compare Open in Sniper

Mkt cap $6.8B

P/E 24.8

Day $101.04 – $104.70

52wk $63.45 – $111.86

Avg vol 1.0M

Beta -0.06

Div yld —

Next earnings 2026-08-06

Quick read

At a glance

LNTH last traded at $103.85, down 0.7% on the day; that's in the upper part of its 52-week range ($63.45–$111.86). Right now it's trading close to its recent average, with no strong stretch in either direction.

The next scheduled earnings report (2026-08-06) is the biggest known catalyst on the calendar, and day to day, watch whether it holds above or slips below its recent average.

A quick snapshot built from the data on this page — not investment advice. Always do your own research.

Today's read

Grading desk →

Price is stretched slightly below its normal range — a light stretch — early days, worth watching. Plus a doji candle — buyers and sellers fought to a draw, which often comes right before a turn.

Long C

Setup score 26 / 100

Price is stretched slightly below its normal range — a light stretch — early days, worth watching. Doji candle.

· KC1 lower stretch — light dip
· Doji — indecision, watch for reversal
· Aligned with weak uptrend

Technical read: KC1 lower, -0.36 ATR from EMA21 · doji

What it means: Price is stretched slightly below its normal range — a light stretch — early days, worth watching. The trigger bar shows a doji candle — buyers and sellers fought to a draw, which often comes right before a turn.

Score split: chart signals 26 / 80 · news & fundamentals checks 0 / 20 — chart signals carry most of the grade.

How this grade was earned

total 26 pts

Cycle position 14

Candle signal 6

Market fit 6

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

Short —

Setup score 15 / 100

Price is sitting close to its normal range — not meaningfully overheated yet. Doji candle.

· Doji — indecision, watch for reversal

Technical read: below KC1 upper, -0.36 ATR from EMA21 · doji

What it means: Price is sitting close to its normal range — not meaningfully overheated yet. The trigger bar shows a doji candle — buyers and sellers fought to a draw, which often comes right before a turn.

Score split: chart signals 15 / 80 · news & fundamentals checks 0 / 20 — chart signals carry most of the grade.

How this grade was earned

total 15 pts

Cycle position 6

Candle signal 6

Market fit 3

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $88.98 (fair range $66–$130); today's price sits 23% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Overvalued -23% margin of safety Accounting: Weak

Intrinsic (DCF)

$88.98

Fair-value range

$65.55 – $129.55

Margin of safety

-23%

Accounting quality Weak

✓ Quick ratio 2.57 (antifragile)
✓ Current ratio 2.70 (antifragile)
✓ Positive retained earnings
✓ Gross margin 60% (pricing power)

⚠ Debt exceeds cash
⚠ Receivables growing faster than revenue

Price implies ~5% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

LNTH is a $6.8 billion company, priced at 25× last year's earnings, and it moves more calmly than the market (beta -0.1).

Market cap $6.8B

P/E ttm 24.8

Beta -0.06

52w range $63.45 – $111.86

Avg volume 1.0M

Dividend yield —

Sector Healthcare

Next earnings 2026-08-06

52-week range · today's price

$63.45$111.86

More on LNTH

Options idea

See more →

CALL $110 2026-08-21

$7.20

PUT $110 2026-08-21

$10.70

Earnings

See more →

Last reported: 2026-05-07
EPS (act / est): 1.46 / 1.23
Surprise: +18.8%
Next report: 2026-08-06

About

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133…